Kouchakzadeh H - Search Results

1

Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology.

Kouchakzadeh H, Shojaosadati SA, Maghsoudi A, Vasheghani Farahani E. Kouchakzadeh H, et al. AAPS PharmSciTech. 2010 Sep;11(3):1206-11. doi: 10.1208/s12249-010-9487-8. Epub 2010 Aug 3. AAPS PharmSciTech. 2010. PMID: 20680708 Free PMC article.

2

Optimization of an anti-HER2 monoclonal antibody targeted delivery system using PEGylated human serum albumin nanoparticles.

Kouchakzadeh H, Shojaosadati SA, Tahmasebi F, Shokri F. Kouchakzadeh H, et al. Int J Pharm. 2013 Apr 15;447(1-2):62-9. doi: 10.1016/j.ijpharm.2013.02.043. Epub 2013 Feb 27. Int J Pharm. 2013. PMID: 23454849

3

Attachment of an anti-MUC1 monoclonal antibody to 5-FU loaded BSA nanoparticles for active targeting of breast cancer cells.

Kouchakzadeh H, Shojaosadati SA, Mohammadnejad J, Paknejad M, Rasaee MJ. Kouchakzadeh H, et al. Hum Antibodies. 2012;21(3-4):49-56. doi: 10.3233/HAB-2012-0261. Hum Antibodies. 2012. PMID: 23549021

4

Efficient delivery of therapeutic agents by using targeted albumin nanoparticles.

Kouchakzadeh H, Safavi MS, Shojaosadati SA. Kouchakzadeh H, et al. Adv Protein Chem Struct Biol. 2015;98:121-43. doi: 10.1016/bs.apcsb.2014.11.002. Epub 2015 Mar 3. Adv Protein Chem Struct Biol. 2015. PMID: 25819278 Review.

5

Targeted Delivery of 5-fluorouracil with Monoclonal Antibody Modified Bovine Serum Albumin Nanoparticles.

Fadaeian G, Shojaosadati SA, Kouchakzadeh H, Shokri F, Soleimani M. Fadaeian G, et al. Among authors: kouchakzadeh h. Iran J Pharm Res. 2015 Spring;14(2):395-405. Iran J Pharm Res. 2015. PMID: 25901146 Free PMC article.

6

Ligand-modified Biopolymeric Nanoparticles as Efficient Tools for Targeted Cancer Therapy.

Kouchakzadeh H, Soudi T, Aghda NH, Shojaosadati SA. Kouchakzadeh H, et al. Curr Pharm Des. 2017;23(35):5336-5348. doi: 10.2174/1381612823666170526101408. Curr Pharm Des. 2017. PMID: 28552063 Review.

7

Efficient harvesting of marine Chlorella vulgaris microalgae utilizing cationic starch nanoparticles by response surface methodology.

Bayat Tork M, Khalilzadeh R, Kouchakzadeh H. Bayat Tork M, et al. Among authors: kouchakzadeh h. Bioresour Technol. 2017 Nov;243:583-588. doi: 10.1016/j.biortech.2017.06.181. Epub 2017 Jul 3. Bioresour Technol. 2017. PMID: 28704739

8

Design, development and evaluation of PEGylated rhGH with preserving its bioactivity at highest level after modification.

Karbasian M, Kouchakzadeh H, Anamaghi PN, Sefidbakht Y. Karbasian M, et al. Among authors: kouchakzadeh h. Int J Pharm. 2019 Feb 25;557:9-17. doi: 10.1016/j.ijpharm.2018.12.034. Epub 2018 Dec 18. Int J Pharm. 2019. PMID: 30576790

9

Antibody-modified magnetic nanoparticles as specific high-efficient cell-separation agents.

Saei A, Asfia S, Kouchakzadeh H, Rahmandoust M. Saei A, et al. Among authors: kouchakzadeh h. J Biomed Mater Res B Appl Biomater. 2020 Aug;108(6):2633-2642. doi: 10.1002/jbm.b.34595. Epub 2020 Mar 14. J Biomed Mater Res B Appl Biomater. 2020. PMID: 32170916

10

Doxorubicin-loaded, pH-sensitive Albumin Nanoparticles for Lung Cancer Cell Targeting.

Aziz A, Sefidbakht Y, Rezaei S, Kouchakzadeh H, Uskoković V. Aziz A, et al. Among authors: kouchakzadeh h. J Pharm Sci. 2022 Apr;111(4):1187-1196. doi: 10.1016/j.xphs.2021.12.006. Epub 2021 Dec 9. J Pharm Sci. 2022. PMID: 34896345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters